| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 46 | 2022 |
| Lung function decline in early HIV infection: impact of antiretroviral drug timing and drug regimen KM Kunisaki, JV Baker, G Collins, DM MacDonald, E Bakowska, ... American journal of respiratory and critical care medicine 201 (6), 739-741, 2020 | 12 | 2020 |
| Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies MK Odutola, E Nnakelu, GG Giles, MT van Leeuwen, CM Vajdic Cancer Causes & Control 31, 979-1000, 2020 | 8 | 2020 |
| Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT E Papot, S Jacoby, D Arlinda, A Avihingsanon, I Azwa, M Borok, D Brown, ... HIV research & clinical practice 23 (1), 37-46, 2022 | 3 | 2022 |
| Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse … G Matthews, S Jacoby, M Borok, N Eriobu, R Kaplan, N Kumarasamy, ... The Lancet HIV, 2024 | 1 | 2024 |
| Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19 NR Aggarwal, J Nordwall, DL Braun, L Chung, J Coslet, T Der, N Eriobu, ... Clinical Infectious Diseases, ciad780, 2024 | 1 | 2024 |
| Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study TO Jensen, TA Murray, GA Grandits, MK Jain, B Grund, K Shaw-Saliba, ... The Lancet Microbe, 2024 | | 2024 |
| Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study PP Nyein, K Petoumenos, M Borok, N Eriobu, N Kumarasamy, ... Clinical Infectious Diseases, ciae256, 2024 | | 2024 |
| Association and Additive Risk of Respiratory and Viral Response Baseline Variables With Mortality in Therapeutics for Inpatients With COVID-19 (TICO) Platform Randomized … NR Aggarwal, J Nordwall, T Der, N Eriobu, AA Ginde, JW Hayanga, ... D93. CLINICAL AND TRANSLATIONAL STUDIES OF COVID-19 CRITICAL ILLNESS, A6556 …, 2023 | | 2023 |
